SK158795A3 - Benzazepines and pharmaceutical compositions on their base - Google Patents
Benzazepines and pharmaceutical compositions on their base Download PDFInfo
- Publication number
- SK158795A3 SK158795A3 SK1587-95A SK158795A SK158795A3 SK 158795 A3 SK158795 A3 SK 158795A3 SK 158795 A SK158795 A SK 158795A SK 158795 A3 SK158795 A3 SK 158795A3
- Authority
- SK
- Slovakia
- Prior art keywords
- neopentyl
- trans
- oxo
- tetrahydro
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36271394A | 1994-12-23 | 1994-12-23 | |
| PCT/IB1995/000424 WO1996020184A1 (fr) | 1994-12-23 | 1995-06-02 | Naphtyl-benzoxazepines ou benzothiazepines inhibitant la squalene synthetase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK158795A3 true SK158795A3 (en) | 1997-01-08 |
Family
ID=23427229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1587-95A SK158795A3 (en) | 1994-12-23 | 1995-06-02 | Benzazepines and pharmaceutical compositions on their base |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5770594A (fr) |
| JP (1) | JPH10500702A (fr) |
| KR (1) | KR960022510A (fr) |
| CN (1) | CN1133287A (fr) |
| AU (1) | AU4067795A (fr) |
| BG (1) | BG100248A (fr) |
| BR (1) | BR9505995A (fr) |
| CA (1) | CA2207772A1 (fr) |
| CZ (1) | CZ344795A3 (fr) |
| FI (1) | FI972696L (fr) |
| GT (1) | GT199500058A (fr) |
| HU (1) | HUT74672A (fr) |
| IL (1) | IL116399A0 (fr) |
| IS (1) | IS4312A (fr) |
| LV (1) | LV11325B (fr) |
| MA (1) | MA23746A1 (fr) |
| MX (1) | MX9704683A (fr) |
| NO (1) | NO955288L (fr) |
| OA (1) | OA10204A (fr) |
| PE (1) | PE60096A1 (fr) |
| PL (1) | PL311997A1 (fr) |
| SI (1) | SI9500393A (fr) |
| SK (1) | SK158795A3 (fr) |
| TN (1) | TNSN95133A1 (fr) |
| TR (1) | TR199501644A2 (fr) |
| WO (1) | WO1996020184A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997048701A1 (fr) * | 1996-06-20 | 1997-12-24 | Pfizer Inc. | 4,1-benzoxazepines ou 4,1-benzothiazepines et leur utilisation comme inhibiteurs de squalene synthetase |
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| DE19716120A1 (de) * | 1997-04-17 | 1998-10-22 | Europ Lab Molekularbiolog | Verwendung von cholesterinsenkenden Mitteln |
| US20060141036A1 (en) * | 1997-12-12 | 2006-06-29 | Andrx Labs Llc | HMG-CoA reductase inhibitor extended release formulation |
| US6403576B1 (en) * | 1998-08-24 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Navy | Antifungal and antiparasitic compounds |
| US20020054871A1 (en) * | 1999-04-12 | 2002-05-09 | Yadong Huang | Methods and compositions for use in the treatment of hyperlipidemia |
| JP2003523948A (ja) * | 1999-11-04 | 2003-08-12 | アンドルクス コーポレーション | アミロイドβ前駆体障害の治療法 |
| US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
| DE60139080D1 (de) | 2000-11-21 | 2009-08-06 | Janssen Pharmaceutica Nv | Farnesyltransferase hemmende benzoheterocyclische derivate |
| WO2008121602A1 (fr) * | 2007-03-29 | 2008-10-09 | Smithkline Beecham Corporation | Composés chimiques |
| GB0803747D0 (en) * | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69332792T2 (de) * | 1992-04-20 | 2004-01-15 | Takeda Chemical Industries Ltd | 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| MX9702175A (es) * | 1994-09-20 | 1997-06-28 | Pfizer | Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol. |
-
1995
- 1995-06-02 JP JP8520314A patent/JPH10500702A/ja active Pending
- 1995-06-02 US US08/860,155 patent/US5770594A/en not_active Expired - Fee Related
- 1995-06-02 MX MX9704683A patent/MX9704683A/es not_active IP Right Cessation
- 1995-06-02 BR BR9505995A patent/BR9505995A/pt not_active Application Discontinuation
- 1995-06-02 WO PCT/IB1995/000424 patent/WO1996020184A1/fr not_active Ceased
- 1995-06-02 SK SK1587-95A patent/SK158795A3/sk unknown
- 1995-06-02 FI FI972696A patent/FI972696L/fi not_active Application Discontinuation
- 1995-06-02 CA CA002207772A patent/CA2207772A1/fr not_active Abandoned
- 1995-12-13 GT GT199500058A patent/GT199500058A/es unknown
- 1995-12-14 IL IL11639995A patent/IL116399A0/xx unknown
- 1995-12-18 MA MA24097A patent/MA23746A1/fr unknown
- 1995-12-18 PE PE1995287390A patent/PE60096A1/es not_active Application Discontinuation
- 1995-12-19 IS IS4312A patent/IS4312A/is unknown
- 1995-12-21 PL PL95311997A patent/PL311997A1/xx unknown
- 1995-12-21 TN TNTNSN95133A patent/TNSN95133A1/fr unknown
- 1995-12-21 LV LVP-95-379A patent/LV11325B/en unknown
- 1995-12-21 BG BG100248A patent/BG100248A/xx unknown
- 1995-12-22 CZ CZ953447A patent/CZ344795A3/cs unknown
- 1995-12-22 AU AU40677/95A patent/AU4067795A/en not_active Abandoned
- 1995-12-22 SI SI9500393A patent/SI9500393A/sl unknown
- 1995-12-22 OA OA60759A patent/OA10204A/en unknown
- 1995-12-22 HU HU9503783A patent/HUT74672A/hu unknown
- 1995-12-22 NO NO955288A patent/NO955288L/no unknown
- 1995-12-22 CN CN95120143A patent/CN1133287A/zh active Pending
- 1995-12-22 TR TR95/01644A patent/TR199501644A2/xx unknown
- 1995-12-22 KR KR1019950054933A patent/KR960022510A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN95133A1 (fr) | 1996-02-06 |
| WO1996020184A1 (fr) | 1996-07-04 |
| IS4312A (is) | 1996-06-24 |
| PL311997A1 (en) | 1996-06-24 |
| MX9704683A (es) | 1997-09-30 |
| GT199500058A (es) | 1997-06-05 |
| FI972696A0 (fi) | 1997-06-23 |
| NO955288D0 (no) | 1995-12-22 |
| CN1133287A (zh) | 1996-10-16 |
| OA10204A (en) | 1996-12-18 |
| HUT74672A (en) | 1997-01-28 |
| US5770594A (en) | 1998-06-23 |
| MA23746A1 (fr) | 1996-07-01 |
| IL116399A0 (en) | 1996-03-31 |
| PE60096A1 (es) | 1996-12-28 |
| KR960022510A (ko) | 1996-07-18 |
| LV11325B (en) | 1997-02-20 |
| BR9505995A (pt) | 1997-12-23 |
| FI972696A7 (fi) | 1997-06-23 |
| JPH10500702A (ja) | 1998-01-20 |
| LV11325A (lv) | 1996-06-20 |
| AU4067795A (en) | 1996-07-04 |
| NO955288L (no) | 1996-06-24 |
| SI9500393A (en) | 1997-04-30 |
| CA2207772A1 (fr) | 1996-07-04 |
| CZ344795A3 (en) | 1996-09-11 |
| FI972696L (fi) | 1997-06-23 |
| BG100248A (bg) | 1996-07-31 |
| HU9503783D0 (en) | 1996-04-29 |
| TR199501644A2 (tr) | 1996-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0724570B1 (fr) | Derives amidino utiles en tant qu'inhibiteurs de la synthase de l'oxyde nitrique | |
| CA2498052C (fr) | Derives heterocycliques | |
| US7101871B2 (en) | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
| RU2145603C1 (ru) | Производные 4,1-бензоксазепина, фармацевтическая композиция, способ ингибирования скваленсинтетазы у млекопитающих, способ ингибирования роста грибков у млекопитающих | |
| US6096736A (en) | Benzazepine derivatives with vasopressin agonistic activity | |
| JP5947906B2 (ja) | 2−ピリジルオキシ−4−ニトリルオレキシン受容体アンタゴニスト | |
| US6166005A (en) | Heterocyclic metalloprotease inhibitors | |
| JPH05140149A (ja) | 縮合複素環誘導体 | |
| JP2009543790A (ja) | 2−置換プロリンビス−アミドオレキシン受容体アンタゴニスト | |
| US5407950A (en) | Arylalkanoylamine derivative and drug containing the same | |
| US20040236102A1 (en) | Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
| AU2002310465A1 (en) | Dipeptidyl peptidase inhibitors for the treatment of diabetes | |
| EP1401828B1 (fr) | Composes de n-formyle hydroxylamine en tant qu'inhibiteurs de peptidyle deformylase (pdf) | |
| AU2003251869A1 (en) | Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes | |
| WO2009026701A1 (fr) | Inhibiteurs de sirtuine | |
| KR20090007371A (ko) | 11-베타-히드록시스테로이드 데히드로게나제 1의 억제제로서의 피페리디닐 치환 피롤리디논 | |
| SK145894A3 (en) | Vinegar acid derivatives, method of their production, pharmaceutical agents on their base and their using | |
| WO2005108382A1 (fr) | Derives de 1,2,4-oxadiazole en tant qu'inhibiteurs de la dipeptidylpeptidase-iv dans le traitement ou la prevention de diabetes | |
| JP2020510044A (ja) | 排出ポンプ阻害剤としてのインドール誘導体 | |
| US5770594A (en) | Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors | |
| JP3202994B2 (ja) | 選却的トロンビン抑制剤として有用な芳香族アミジン誘導体 | |
| KR19990014070A (ko) | 파네실 전이효소 저해활성을 갖는 히단토인 유도체 | |
| HU195200B (en) | Process for producing oxo-thiazolidine compounds and pharmaceutical preparations comprising the same | |
| Suh et al. | Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)-and [(acylthio) alkanoyl] glycine derivatives | |
| CZ293605B6 (cs) | Tetrahydrochinolinový derivát, způsob jeho výroby a farmaceutický prostředek |